Ignacio Garrido‐Laguna

Also affiliated with Huntsman Cancer Institute, University of Utah Health Care

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma”.

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1215

N/A

1.3DataRank · unranked

41 citations

Haeseong Park, S. Greg Call, Kiran Madwani, Yasuhiro Oki, Vivek Subbiah +17 more

Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0535

N/A

0.512DataRank · unranked

12 citations

Devora Delman, Jiayi Yu, Mingen Liu, Joey H. Li, Liti Zhang +8 more

Case series examining somatic test results for patients with hereditary cancer syndromes associated with gastrointestinal cancer risk.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.680

N/A

0DataRank · unranked

0 citations

Cathryn Koptiuch, Samantha Greenberg, Gammon Amanda, Chris Nevala-Plagemann, Jennie Vagher +5 more

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1789

N/A

0DataRank · unranked

53 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma

Neoplasia(2021)10.1016/j.neo.2021.06.005

N/A

0DataRank · unranked

14 citations

Sabine Hellwig, David A. Nix, Mary P. Bronner, Alun Thomas, Carrie L. Fuertes +6 more

Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma

Hepatology(2021)10.1002/hep.31706

N/A

0DataRank · unranked

21 citations

Ignacio Garrido‐Laguna, Kimberley Evason, Sharanya Maanasi Kalasekar

Immunologic predictors of therapeutic response to neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma (PDA) in SWOG S1505.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.419

N/A

0DataRank · unranked

2 citations

Mai T. Duong, Renee B. Chang, Yuqing Xue, Devora Delman, Ignacio Garrido‐Laguna +15 more

Discrepancies between tumor genomic profiling and germline genetic testing

ESMO Open(2022)10.1016/j.esmoop.2022.100526

N/A

0DataRank · unranked

21 citations

Cathryn Koptiuch, Samantha Greenberg, Wendy Kohlmann, Joanne Jeter, Sarah V. Colonna +8 more

Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study

BMC Cancer(2022)10.1186/s12885-022-10130-4

N/A

0DataRank · unranked

14 citations

Chris Nevala-Plagemann, Jian Ying, Vaia Florou, Benjamin Haaland, Ignacio Garrido‐Laguna +1 more

Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer in the United States

Journal of the National Comprehensive Cancer Network(2022)10.6004/jnccn.2021.7079

N/A

0DataRank · unranked

4 citations

Siddharth Iyengar, Andrew D. Trunk, Lisa M. Pappas, Benjamin Haaland, Ignacio Garrido‐Laguna +1 more

A multi-analyte serum biomarker panel for early detection of pancreatic adenocarcinoma

medRxiv(2022)10.1101/2022.03.03.22271867

N/A

0DataRank · unranked

2 citations

Kenneth M. Boucher, Josh Bleicher, Gayatri D. Khanderao, Alessandra Rosati, Katherine E. Poruk +14 more

Comparing outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: A retrospective study

Research Square(2022)10.21203/rs.3.rs-1490065/v1

N/A

0DataRank · unranked

0 citations

Chris Nevala-Plagemann, Jian Ying, Vaia Florou, Benjamin Haaland, Ignacio Garrido‐Laguna +1 more

Feasibility and acceptability of an mHealth, home-based exercise intervention in colorectal cancer survivors: A pilot randomized controlled trial

PLoS ONE(2023)10.1371/journal.pone.0287152

N/A

0DataRank · unranked

18 citations

Nathan B. Rose, Austin F. Johnson, Emily R. Dunston, Ignacio Garrido‐Laguna, Paula Hobson +4 more

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3724

N/A

0DataRank · unranked

24 citations

Andrew Elliott, Matthew H. Bailey, David Stone, Kajsa E. Affolter, Heloisa P. Soares +9 more

A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7082

N/A

0DataRank · unranked

17 citations

Shashank Sama, Jian Ying, Jincheng Shen, Benjamin Haaland, Vaia Florou +2 more

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007440

N/A

0DataRank · unranked

14 citations

Charalampos S. Floudas, Asaf Maoz, Abdul Rafeh Naqash, Carter Norton, Aik Choon Tan +12 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176.v1

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma

Gastroenterology(2024)10.1053/j.gastro.2024.01.013

N/A

0DataRank · unranked

18 citations

Sarah Colby, Ignacio Garrido‐Laguna, Yuqing Xue, Renee B. Chang, Devora Delman +14 more

KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma

JAMA Network Open(2025)10.1001/jamanetworkopen.2024.53588

N/A

0DataRank · unranked

34 citations

Matthew Shaw, Zachary Rubnitz, Jarrod Smith, Heloisa P. Soares, Chris Nevala-Plagemann +3 more

6MO: Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology(2025)10.1016/s1556-0864(25)00201-1

N/A

0DataRank · unranked

16 citations

Dehan Hong, Jia Luo, S-H.I. Ou, M.L. Johnson, A.I. Spira +10 more

Impact of DNA damage repair alterations on real-world response to therapy in metastatic colorectal cancer

ESMO Open(2025)10.1016/j.esmoop.2025.105768

N/A

0DataRank · unranked

1 citations

Christine Norton, Zachary Rubnitz, Vaia Florou, Chris Nevala-Plagemann, Ignacio Garrido‐Laguna +1 more

The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA

PLoS ONE(2020)10.1371/journal.pone.0229063

N/A

0DataRank · unranked

14 citations

Sabine Hellwig, Christopher J. Conley, Alun Thomas, Carrie L. Fuertes, Cindy Hamil +6 more